BioCryst公司的贝罗司他胶囊效果好不好

Orladeyo是血浆激肽释放酶抑制剂，贝罗司他胶囊Orladeyo可预防12岁以上成人和儿科患者的遗传性血管性水肿（HAE）。

BioCryst Corporation is a biotechnology company. BioCryst designs, optimizes and develops small molecule drugs that block enzymes involved in disease pathogenesis. The company focuses on treating rare diseases. BioCryst公司运用X光散射技术、分子结构计算机模拟和化学技术集中研究控制细胞生物学的酶的三维分子结构及活性部位特征。 Are BioCryst’s berosostat capsules effective?

在关键的3期APeX-2试验中，BioCryst公司可显著减少患者24周内遗传性血管性水肿HAE发作次数，并且持续至第48周。 Patients who completed the 48-week trial experienced a significant reduction in the frequency of hereditary angioedema HAE attacks, from an average of 2.9 attacks/month at baseline to an average of 1 attack/month. Completion of another long-term open-label APeX-S study reduced the frequency of HAE attacks in patients with hereditary angioedema to an average of 0.8 episodes per month.由此可见，贝罗司他胶囊Orladeyo的治疗效果是十分显著的，该药品的研制成功对于很多患者来说是一个好消息。

Recommended dosage of Orladeyo: take one capsule (150 mg) once daily with food. 患者在接受贝罗司他胶囊Orladeyo治疗期间，不可擅自增加或减少药物剂量，增加药物剂量不会使病情迅速好转，反而会导致不良反应的发生，因此患者应严格按照医生的诊疗建议用药，不可擅自用药治疗。

以上就是关于Orladeyo的介绍，患者若对Orladeyo还有其他疑问（如药品价格，购买渠道等），可以向医伴旅客服咨询。

Recommended related hot articles: /newsDetail/96467.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.